Skip to content
Rapid Craft Today

The Zimbabwean Government Turns Down ‘Unbalanced’ American Healthcare Assistance Agreement Because of Information Apprehensions

Health aid image
The offered US financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a major American health deal worth 367 million US dollars (£272m) spanning five years over the United States' request for confidential data.

This move came to light after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesman later explained that the US was seeking genetic material for research and commercial gain while was unwilling to share the benefits from any future medical innovations.

"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged continued dialogue to secure a agreement suitable to both sides so the country's critical HIV programme can proceed.

Wider Implications

This rejection follows a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement following concerns were raised about the security of Kenyans' health data.

After resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.

As per statements, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.

"Effectively, our nation would provide the raw materials for scientific discovery without any assurance that the end products would be available to our citizens should a new disease outbreak emerge."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures already established via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.

"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."

The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome further dialogue with our American counterparts on how future collaboration might be structured in a way that honours the sovereignty and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that negotiations must proceed considering much of the nation's Aids initiatives were funded by foreign aid.

"If specific concerns exist, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group added.

This impasse emphasises the continuing debate between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.

About the author

Stephanie Boyd

Creative director and DIY enthusiast with a passion for upcycling and modern crafts.

Rapid Craft Today

Type to search articles.